Qin Liu

Qin Liu

Company: Harvard Medical School

Job title: Assistant Professor of Ophthalmology


Dr. Liu’s research focuses on improving the understanding of the genetic causes and molecular bases of inherited retinal degenerations (IRDs), and developing novel CRISPR/Cas9-based gene editing therapeutic approaches to overcome hurdles of conventional AAV-mediated gene augmentation therapy for treating dominant IRDs and recessive IRDs that are caused by mutations in large genes. In pursuing this, she has been testing and employing a variety of the most cutting-edge gene editing technologies, both in vitro in cell-based model systems and in vivo using a number of animal models. Her research has led to a number of inventions that in the process of seeking patent protection.


Exploring Next-Generation Therapeutics: The Promise of Gene Editing 4:30 pm

• Exploring the use of various gene editing technologies to treat inherited eye diseases • Investigating the unique challenges associated with gene editing compounded with challenges of gene therapy • Discussing recent data highlighting innovations of gene edited gene therapies to treat ophthalmic disordersRead more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.